A new quantitative systems pharmacology model spanning all three classes of BRAF-mutant lung cancer predicts that MEK-ERK ...
A Thai prospective study used plasma-based 52-gene sequencing to map how T790M-positive lung cancers resist osimertinib, ...
In a phase 2 study, Ojemda (tovorafenib) led to responses in 43% of adults with melanoma or other solid tumors that carried rare RAF gene changes. Ojemda (tovorafenib) shrank tumors in 10 of 23 adults ...
A Hong Kong model compared upfront NGS with EGFR/ALK-first testing in metastatic NSCLC, highlighting trade-offs in cost, ...
Early-onset colorectal cancer with liver-only metastases can have significant differences in biology from late-onset malignancies.A study of nearly 1,700 individuals from Australia showed early-onset ...
Brain metastasis from melanoma is particularly deadly and options are limited due to the difficulty of breaching the brain-blood barrier. Recent research illustrated the potent and prolonged antitumor ...
"If I am diagnosed with colorectal cancer, what kind of treatment will I receive?""What types of anticancer drugs are there?
Administering Keytruda via subcutaneous injection instead of an intravenous drip.In September 2026, such a drug was approved.
Academician Zhong Nanshan's team, in collaboration with KingMed Diagnostics, unveiled DeepGEM 2.0, a multimodal AI pathology model for lung ...
OncoDaily’s Northeast GI Oncology Congress 2026 will take place November 19–21 in Boston, Massachusetts, bringing clinicians, ...
Once upon a time. Once upon a time, there was cancer. Or rather: it’s still here, but it’s no longer like the villain in ...
MedPage Today on MSN
Therapeutic evolution in gastroesophageal adenocarcinoma
Despite treatment advances and better outcomes, precision guidance still missing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results